Patents by Inventor Mark Freyberg

Mark Freyberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents, Which Inhibit Apoptosis in Cells that are Involved in Wound Healing
    Publication number: 20100111931
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterized in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombospondin-1 in such a way that the bond between thrombospondin-1 and IAP and/or integrin ?v?3 is inhibited.
    Type: Application
    Filed: August 28, 2009
    Publication date: May 6, 2010
    Applicant: DERMATOOLS BIOTECH GMBH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Agents, which inhibit apoptosis in cells that are involved in wound healing
    Patent number: 7582725
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: September 1, 2009
    Assignee: Dermatools Biotech GmbH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Method for Manufacturing Specific Binding Molecules Against Selected Target Molecules, Kit, and Binding Molecules
    Publication number: 20080003563
    Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.
    Type: Application
    Filed: April 29, 2005
    Publication date: January 3, 2008
    Inventors: Gerd Klock, Dirk Kaiser, Mark Freyberg
  • Anti-apoptotically active apatamers
    Publication number: 20070117768
    Abstract: The invention relates to anti-apoptotically active apatamers. The invention describes possible therapeutic and diagnostic applications for, among other things, treating arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases.
    Type: Application
    Filed: December 10, 2004
    Publication date: May 24, 2007
    Applicant: CYTOTOOLS GMBH
    Inventors: Gerd Klock, Mark Freyberg, Dirk Kaiser
  • Method for identifying active anti-apoptosis compounds
    Publication number: 20060172921
    Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.
    Type: Application
    Filed: January 6, 2006
    Publication date: August 3, 2006
    Applicant: CYTOTOOLS GMBH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Apoptotically active peptides
    Publication number: 20050222020
    Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.
    Type: Application
    Filed: December 18, 2002
    Publication date: October 6, 2005
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser